People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cesca Therapeutics Inc. | — | Biotechnology | Series A | $34.6M | $29.2M | 2018 |
Jeff Cauble at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Cauble on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Haihong Zhu | 1 | 2 |
| Mark Westgate | 1 | 2 |
| Vivian Liu | 1 | 2 |
| Michael C Rhein | 1 | 1 |
| Craig W Moore | 1 | 1 |
| Kenneth C Pappa | 1 | 1 |
| Mahendra W Rao | 1 | 1 |
| Kenneth W Harris | 1 | 1 |
| Mitchel C Sivilotti | 1 | 1 |
| Mike C Bruch | 1 | 1 |
| Robin C Stacey | 1 | 1 |
| Robin Stracey | 1 | 1 |
| Michael Bruch | 1 | 1 |
| Denis Michael Rhein | 1 | 1 |
| Mahendra S. Rao | 1 | 1 |
| Xiaochun Xu | 1 | 1 |
| Joseph Thomis | 1 | 1 |
| Russell Medford | 1 | 1 |
| Jeffery Cauble | 1 | 1 |
| James Xu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.